BYDUREON Trademark

Trademark Overview

On Wednesday, May 25, 2011, a trademark application was filed for BYDUREON with the United States Patent and Trademark Office. The USPTO has given the BYDUREON trademark a serial number of 85329947. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, January 20, 2022. This trademark is owned by Amylin Pharmaceuticals, Inc.. The BYDUREON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, and diabetes
bydureon

General Information

Serial Number85329947
Word MarkBYDUREON
Filing DateWednesday, May 25, 2011
Status800 - REGISTERED AND RENEWED
Status DateThursday, January 20, 2022
Registration Number4169150
Registration DateTuesday, July 3, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, and diabetes
Pseudo MarkBY DUREON

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 2, 2011
Primary Code005
First Use Anywhere DateWednesday, February 8, 2012
First Use In Commerce DateWednesday, February 8, 2012

Trademark Owner History

Party NameAMYLIN PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19803
Party NameAmylin Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, January 20, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, January 20, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, January 20, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 20, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 10, 2021TEAS SECTION 8 & 9 RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, July 3, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, April 12, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, April 12, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, April 11, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 2, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, July 3, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 31, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 3, 2012REGISTERED-PRINCIPAL REGISTER
Saturday, May 26, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 25, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, May 22, 2012ASSIGNED TO LIE
Saturday, May 5, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 30, 2012STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 5, 2012USE AMENDMENT FILED
Friday, April 27, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 5, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, December 20, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2011PUBLISHED FOR OPPOSITION
Friday, September 16, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 12, 2011ASSIGNED TO EXAMINER
Friday, June 3, 2011NOTICE OF PSEUDO MARK MAILED
Thursday, June 2, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 28, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

bydureon disorders preparations pharmaceutical endocrine diabetes conditions prevention namely treatment metabolic